Literature DB >> 2832328

Regional vascular effects of serotonin and ketanserin in young, healthy subjects.

G J Blauw1, P van Brummelen, P C Chang, P Vermeij, P A van Zwieten.   

Abstract

The local hemodynamic effects of serotonin (5-hydroxytryptamine; 5-HT) and the selective 5-HT2 antagonist ketanserin were investigated in the forearm of 20 healthy volunteers. Single doses of 5-HT (0.1-80 ng/kg/min) and ketanserin (5-125 ng/kg/min) were administered intra-arterially. The relative alpha 1-adrenergic receptor and 5-HT2 blocking potencies of ketanserin were investigated using intra-arterial infusions of cumulative doses of methoxamine (0.1, 0.3, and 0.5 microgram/kg/min), tyramine (0.25, 0.50, and 1.25 microgram/kg/min), and 5-HT (10, 30, and 80 ng/kg/min) together with a low dose (5 ng/kg/min) and a high dose (50 ng/kg/min) of ketanserin. Forearm blood flow was measured by venous occlusion plethysmography. Heart rate and intra-arterial blood pressure were recorded semicontinuously. Intra-arterial infusion of 5-HT induced an initial transient vasodilatation, followed by a steady vasodilatation for the low doses of 5-HT (0.1-10 ng/kg/min; p less than 0.05). A steady vasoconstriction was only obtained at the highest dose of 5-HT. Ketanserin induced a dose-dependent increase in forearm blood flow from 15 ng/kg/min (p less than 0.05) onward. The vasodilatation induced by 5-HT (1 ng/kg/min) was significantly enhanced by ketanserin (125 ng/kg/min; p less than 0.05), whereas the vasoconstriction elicited by 5-HT (80 ng/kg/min) was reversed by ketanserin (50 ng/kg/min; p less than 0.05), thus confirming that 5-HT2 receptors were stimulated by 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832328     DOI: 10.1161/01.hyp.11.3.256

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 3.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

4.  The effects of a selective 5-HT2 receptor antagonist (ICI 170,809) on platelet aggregation and pupillary responses in healthy volunteers.

Authors:  D S Millson; C L Jessup; A Swaisland; S Haworth; A Rushton; J D Harry
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

5.  Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.

Authors:  G J Blauw; C J Doorenbos; T A Bruning; P van Brummelen; P A van Zwieten
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers.

Authors:  D S Millson; S J Haworth; A Rushton; D Wilkinson; S Hobson; J Harry
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

7.  Arterial dilatation and venous constriction induced by serotonin in the elderly.

Authors:  G J Blauw; P van Brummelen; P C Chang; P Vermeij; P A van Zwieten
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 8.  Pharmacology of antihypertensive agents with multiple actions.

Authors:  P A van Zwieten
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.

Authors:  B Marasini; C Bassani
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

10.  Effects of serotonin and noradrenaline on superficial hand veins in patients with primary hypertension and in healthy volunteers.

Authors:  M Wolzt; E Schmidt; B Wagner; S Schuller-Petrovic; P A Kyrle; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.